Znn3bq.jpeg
²é¿´: 1770  |  »Ø¸´: 9
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

entremed

Í­³æ (СÓÐÃûÆø)

[½»Á÷] ÄÉ˹´ï¿ËÉÏÊÐÍâÆóÕÐÆ¸CRAÒ»Ãû

¾ßÌ幤×÷µØµã:
±±¾© ³¯Ñô ºô¼ÒÂ¥
н½ð:
Óźñ
ÕÐÆ¸¸Úλ:
CRO£¬ÁÙ´²¼à²ìÔ±
ÁªÏµ·½Ê½:
010-65086067

ְλ:  ÁÙ´²¼à²éÔ±

ÈÎÖ°×ʸñ£º

•        ÉúÃü¿ÆÑ§Ïà¹Ø×¨Òµ´óר¼°ÒÔÉÏѧÀú
•        ¾ßÓÐ2ÄêÒÔÉϵÄCRA¡¢CRC»òÁÙ´²ÊÔÑéCRO¹«Ë¾µÄÏà¹Ø¹¤×÷¾­Ñ飬ÓÐÖ×ÁöÁÙ´²Ñо¿¼à²é¹¤×÷¾­ÀúÕßÓÅÏÈ
•        ÊìϤI/IIÆÚÁÙ´²ÊÔÑé¾ßÌåÁ÷³ÌºÍGCP¼°CFDAµÄÏà¹Ø·¨ÂÉ·¨¹æ£»ÓÐÍâ×ÊÒ©³§»ò¹ú¼Ê¶àÖÐÐÄÏîÄ¿¾­ÑéÕßÓÅÏÈ
•        ½ÏÇ¿µÄÈ˼ʹµÍ¨Óë×éÖ¯¹ÜÀí¼¼ÇÉ£¬¾ßÓÐÁ¼ºÃµÄ¹µÍ¨ºÍЭµ÷ÄÜÁ¦£¬ÉÆÓÚ´¦ÀíÓëÁÙ´²Ñо¿ÖÐÐŤ×÷ÈËÔ±µÄ¹ØÏµ£¬
•        ¾ßÓÐÁ¼ºÃµÄÖ°ÒµµÀµÂ¼°½ÏÇ¿µÄÔðÈÎÐÄ£¬¾ßÓжÀÁ¢¹¤×÷µÄÄÜÁ¦


ְλÃèÊö:
•        ²ÎÓëÖ´ÐÐÖÐÐÄÑ¡Ôñ¼°±ê×¼ÆÀ¼Û¹¤×÷£¬Ð­ÖúÁÙ´²ÊÔÑéµÄ×¼±¸¡¢Æô¶¯¡¢ÊµÊ©ºÍ¼à²é¹ÜÀí¹¤×÷£¬Ð­µ÷×éÖ¯Ñо¿Õß»áÒ飻

•        Ö´ÐÐÖÐÐÄÆô¶¯¼°¹Ø±Õ£¬ÅàѵµÈÏà¹Ø¹¤×÷£¬¶Ô¸÷Ñо¿ÖÐÐÄʵʩ³£¹æ·ÃÊÓ£¬ÔÚÑо¿ÖÐÐÄÓëÏîÄ¿¹ÜÀíÍŶÓÖ®¼ä±£³ÖÁ¼ºÃÓÐЧµÄ¹µÍ¨½»Á÷£¬ÎªÑо¿ÕßÌṩÓмÛÖµµÄ½¨ÒéºÍ°ïÖú¼°Ê±·´Ó³²¢½â¾ö´æÔÚµÄÎÊÌ⣻±£³ÖÓëËùÓÐÑо¿ÕßÖ®¼äÁ¼ºÃµÄºÏ×÷¹ØÏµ£¬Ð­µ÷ÊÔÑé¸÷·½¹ØÏµ£»È·±£Ñо¿ÖÐÐĵĸ÷Ï×÷·ûºÏGCP£¬ICH¼°SOPµÈ¸÷Ïî·¨¹æÖƶÈÒªÇó¡£

•        ºË²éÑо¿ÖÐÐĵÄԭʼÊý¾Ý£¬×¼±¸¡¢ÊÕ¼¯ËùÓÐÑо¿ÖÐÐÄÏà¹ØµÄÎļþ£¬½â¾ö¸÷ÖÖÓëÖ®Ïà¹ØµÄÎÊÌ⼰ʱ´¦Àí¸÷ÀàÊÔÑéÏà¹ØµÄÎÊÌ⣬ȷ±£ÁÙ´²ÊÔÑéÊý¾Ý¿ÆÑ§¿É¿¿²¢¼°Ê±ÊÕ¼¯£¬È·±£CRF¼Ç¼׼ȷ¡¢ÍêÕû£¬½øÐÐԭʼÊý¾ÝµÄºË¶Ô£¬°´ÒªÇó¼°Ê±Íê³É¼à²é±¨¸æ¡£

•        Эµ÷CROºÍ¸÷Ñо¿ÖÐÐĵŤ×÷£¬ÒÔÈ·±£°´ÕÕʱ¼ä±íÍê³É²¡ÀýµÄÈë×鹤×÷£¬È·±£Ñо¿ÖÐÐĵĽøÕ¹·ûºÏÑо¿¼Æ»®½ø¶ÈÒªÇó£»

  
ÎÒÃǽ«Ìṩ¸øÔ±¹¤£º
        Á¼ºÃ¹¤×÷·ÕΧ
        ÎåÏÕÒ»½ðµÈн×ʸ£Àû´ýÓö
        ¸÷ÖÖÅàѵºÍ·¢Õ¹¿Õ¼ä

Ó¢´´Ô¶´ï£¨±±¾©£©ÉúÎïÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾³ÉÁ¢ÓÚ2012Äê8Ô¡£ÎªÃÀ¹úNASDAQÉÏÊй«Ë¾,Ŀǰ¹«Ë¾¹É·ÝÔ¼2200Íò¹É£¬ÊÐÖµÔ¼3000ÍòÃÀÔª¡£ÖÂÁ¦ÓÚС·Ö×Ó°ÐÏòÖÎÁÆÖ×Áö¡¢×ÔÉíÃâÒß²¡µÄÐÂÒ©¿ª·¢¡£¹«Ë¾ÔÚÃÀ¹úÂíÀïÀ¼ÖÝÉèÓÐ×ܲ¿¡£°ì¹«µØµãΪ±±¾©Êг¯ÑôÇø¶«Èý»·£¬¹«Ë¾Ä¿Ç°ÔÚº£µíÇøÉèÁ¢ÊµÑéÊÒÖÂÁ¦ÓÚÐÂÒ©Ñз¢¡£
ĿǰÓÐ2¸ö²úÆ·ÔÚÃÀ¹ú¾­FDAÅú×¼½øÈëÁÙ´²Ñо¿×¨×¢Ð¡·Ö×Ó°ÐÏòÖÎÁÆÖ×Áö¡¢×ÔÉíÃâÒßµÄÐÂÒ©¿ª·¢£¬Ä¿Ç°ÒÑÓп¹ÈéÏÙ°©Ò»ÀàÐÂÒ©½øÈëIIÆÚÁÙ´²Ñо¿½×¶Î¡£
Ö÷ÒªÑо¿ÕßJennifer R. Diamond, ҽѧ²©Ê¿£¬ÃÀ¹ú¿ÆÂÞÀ­¶à´óѧҽѧԺ Ö×ÁöÑо¿ÖÐÐÄ£¬ÃÀ¹úÖøÃûÈéÏÙ°©×¨¼Ò¡£Ö÷ÒªÑо¿ÕßKathy Miller, MD£¬Ò½Ñ§²©Ê¿£¬ÃÀ¹úÓ¡µÚ°²ÄÉ´óѧҽѧԺ Ö×ÁöÑо¿ÖÐÐÄ£¬ÃÀ¹úÖøÃûÈéÏÙ°©×¨¼Ò¡£
Ö´Ðж­Ê³¤Wei-wu He ²©Ê¿£¬IDG×ʱ¾·çÏÕͶ×ʺϻïÈË£¬°ÁÈñ¶«Ô´£¨ÃÀ¹ú¡¢±±¾©¡¢ÎÞÎý£©¹«Ë¾¶­Ê³¤¡¢Ê×ϯִÐй٣¬¹þ·ð´óѧ²©Ê¿ºó£¬±´ÀÕҽѧԺ²©Ê¿£¬ÃÀ¹úÎÖ¶ÙÉÌѧԺ¹¤É̹ÜÀí˶ʿ¡£
Ê×ϯִÐй٣¬Ken Ren ²©Ê¿£¬ÃÀ¹úÂå¿Ë·ÆÀÕ´óѧ²©Ê¿ºó£¬Å¦Ô¼ÖÝÁ¢´óѧ²©Ê¿£¬Ç廪´óѧÖйúÆóÒµ¼Ò׿ԽÁìµ¼È˸߼¶ÑÐÐÞ°àÓÅÐãѧԱ¡£
¹«Ë¾Ä¿Ç°ÔÚ±±¾©Êк£µíÇøÖйشåÉúÎïÒ½Ò©ÔºÉèÁ¢ÊµÑéÊÒ£¬½øÐÐÐÂÒ©Ñз¢µÈÏîÄ¿¡£
CASI Pharmaceuticals¹«Ë¾ÊÇÈ«ÃÀ°©Ö¢Ñо¿»ù½ð»á°ä·¢µÄµÚÆß½ìÊ¥½Ý¶û¼ªµÄ×î´óÔÞÖúÉÌ¡£
CASI Pharmaceuticals, Inc. is a NASDAQ listed public company with a stock code: CASI. It is a clinical-stage pharmaceutical company employing a drug development strategy primarily in the United States and China to develop targeted therapeutics for the global oncology market. Its lead compound, ENMD-2076, a selective angiogenic kinase inhibitor, has completed several Phase 1 studies in solid tumors, multiple myeloma, and leukemia, and is currently completing a multi-center Phase 2 study in ovarian cancer. The Company has a wholly owned subsidiary, CASI Pharmaceuticals (Beijing) Co. Ltd., in Beijing, China with headquarters in Chaoyang business district. Additional information about CASI Pharmaceuticals is available on the Company's web site at www.casipharmaceuticals.com.
Ó¢´´Ô¶´ï£¨±±¾©£©ÉúÎïÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾
µØ    Ö·£º³¯ÑôÇøÏò¾ü±±Àï28ºÅÔº1ºÅÂ¥716ÊÒ   
ÓÊÕþ±àÂ룺100020
ÓÐÒâÏòµÄ¿ÉÒÔ·¢ËÍÓʼþµ½tomz@casipharmaceuticals.com »òÕß gloryli@casipharmaceuticals.com

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

entremed

Í­³æ (СÓÐÃûÆø)

7Â¥2014-07-11 12:44:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 10 ¸ö»Ø´ð

entremed

Í­³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
2Â¥: Originally posted by ljqpyk at 2014-07-10 13:51:21

3Â¥2014-07-10 14:27:04
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

entremed

Í­³æ (СÓÐÃûÆø)

😊😊😊😊😊😊😊😊😊😊😊

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
4Â¥2014-07-10 22:32:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

LuciferZero

ľ³æ (ÕýʽдÊÖ)

¡ï
entremed: ½ð±Ò+1 2014-07-15 10:05:02
Ò©ÎïÑз¢µÄС³æ°ï¶¥
8Â¥2014-07-15 07:10:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÄÏÀí¹¤´óѧ331·Ö²ÄÁÏÇóµ÷¼Á +9 ÌìÏÂww 2026-04-09 9/450 2026-04-10 22:58 by Ftglcn90
[¿¼ÑÐ] 284Çóµ÷¼Á +9 ÈÃÎÒÉϰ¶°É°¢Î÷ 2026-04-09 11/550 2026-04-10 19:18 by ¾¸jing
[¿¼ÑÐ] µ÷¼Á +19 ²»·ê´º 2026-04-05 20/1000 2026-04-10 10:15 by may_ÐÂÓî
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +5 hzhahg 2026-04-06 5/250 2026-04-10 10:10 by may_ÐÂÓî
[¿¼ÑÐ] 292Çóµ÷¼Á +9 ЦЦԬ 2026-04-09 9/450 2026-04-10 10:05 by LHGeng
[¿¼ÑÐ] 301Çóµ÷¼Á +4 XYPLR 2026-04-05 6/300 2026-04-10 09:17 by Delta2012
[¿¼ÑÐ] 297Çóµ÷¼Á +8 Kwgyz 2026-04-09 8/400 2026-04-09 23:22 by may_ÐÂÓî
[¿¼ÑÐ] 085500Çóµ÷¼Á²ÄÁÏ +8 Ò×11122 2026-04-09 8/400 2026-04-09 23:15 by parmtree
[¿¼ÑÐ] Çóµ÷¼Á +5 archer.. 2026-04-09 7/350 2026-04-09 22:18 by lbsjt
[¿¼ÑÐ] ¿¼Ñе÷¼Á +13 ±ù±ù£¬£¬£¬ 2026-04-07 13/650 2026-04-09 17:01 by Lilly_Li
[¿¼ÑÐ] »¯Ñ§308·ÖÇóµ÷¼Á +21 ÄãºÃÃ÷ÌìÄãºÃ 2026-04-07 23/1150 2026-04-08 22:32 by ¿­¿­Òª±ä˧
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£ÖÝ´óѧ085600Çóµ÷¼Á +21 ³ÔµÄ²»ÉÙ 2026-04-05 24/1200 2026-04-08 16:47 by sunhuadong
[¿¼ÑÐ] 285Çóµ÷¼Á +7 ¶ñ·¨´ó¶þµÄÆøÎ¶ß 2026-04-05 10/500 2026-04-08 14:34 by zhq0425
[¿¼ÑÐ] 263·ÖBÇøÇóµ÷¼Á +6 Àînihao 2026-04-08 6/300 2026-04-08 09:38 by ÄÏ¿ªÐ¡ôë
[¿¼ÑÐ] 304Çóµ÷¼Á +10 ËØÄê¼ÀÓï 2026-04-06 17/850 2026-04-08 09:05 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 307Çóµ÷¼Á +14 ³¬¼¶ÒÁ°º´óÍõ 2026-04-06 14/700 2026-04-08 07:03 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 316Çóµ÷¼Á +4 15318418673 2026-04-07 4/200 2026-04-07 22:12 by hemengdong
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +4 ´Þwj 2026-04-04 5/250 2026-04-05 14:06 by imissbao
[¿¼ÑÐ] ¿¼Ñе÷¼Á +3 mcbbc 2026-04-04 3/150 2026-04-05 10:03 by barlinike
[¿¼ÑÐ] Ò»Ö¾Ô¸»¦9£¬ÇóÉúÎïѧµ÷¼Á£¬326·Ö +6 Áõīī 2026-04-04 6/300 2026-04-04 19:44 by ÌÆãå¶ù
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û